Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| METLIFE INCMET · Entity 488 | EVP & Chief Risk Officer | August 31, 2026 | September 02, 2026 |
| RAYMOND JAMES FINANCIAL INCRJF · Entity 3126 | Director | February 19, 2026 | February 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
METLIFE INC
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 150,350 |
Reported balance
After 2026-08-31 transaction · row 1
1 source rowRow 1 · 2026-08-31 · Tax withholding · Disposed 4,030 · Balance 150,350 F1: Withheld for taxes on shares issued for restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Withheld for taxes on shares issued for restricted stock units.
RAYMOND JAMES FINANCIAL INC
Report date February 19, 2026 · Filed February 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,820 |
Reported balance
After 2026-02-19 transaction · row 1
1 source rowRow 1 · 2026-02-19 · Exercise / conversion · Acquired 1,253 · Balance 8,820 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,556 |
Reported balance
After 2026-02-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-19 · Grant · Acquired 1,303 · Balance 2,556 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,303 |
Reported balance
After 2026-02-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-19 · Exercise / conversion · Disposed 1,253 · Balance 1,303 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F3: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.
F2: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027.
F3: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2022 Filed Feb 25, 2022 20:08 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | GrantRestricted Stock Units · Derivative | 1,683 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003348 · doc4.xml · derivative · entry 2 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,608 Underlying: Common Stock · 1,683 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · derivative.exercise_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2023. F2 · derivative.expiration_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2023. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 20:08 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionCommon Stock | 1,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003348 · doc4.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:59 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 15,986 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000032 · wf-form4_164575076470102.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,986 Underlying: Common Stock · 15,986 shares Expires 2032-02-21 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:59 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 4,098 | $68.96 | $282,598.08 |
DisclosureSEC source: 0001099219-22-000032 · wf-form4_164575076470102.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,657 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:59 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 11,313 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000032 · wf-form4_164575076470102.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,755 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:59 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 5,330 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000032 · wf-form4_164575076470102.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,442 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 16:04 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionRestricted Stock Units · Derivative | 605 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014433 · doc4.xml · derivative · entry 2 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 605 shares Expires 2021-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · balance_after: The RSU grant was previously reported as covering 403 shares awarded on December 2, 2020, but was adjusted to reflect the 3-for-2 stock split by means of a stock dividend that occurred on September 21, 2021. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 16:04 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionCommon Stock | 605 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014433 · doc4.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:58 UTC | METLIFE INC MET · Entity 488 | SaleCommon Stock | 11,000 | $64.58 | $710,425.10 |
DisclosureSEC source: 0001099219-21-000180 · wf-form4_162085312209988.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,112 F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices of $64.58 to $64.5902, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:57 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 405 | $58.96 | $23,878.80 |
DisclosureSEC source: 0001099219-21-000096 · wf-form4_161480861685146.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,112 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:57 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 954 | $59.44 | $56,705.76 |
DisclosureSEC source: 0001099219-21-000096 · wf-form4_161480861685146.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,517 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 15,674 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000075 · wf-form4_161429251319284.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,674 Underlying: Common Stock · 15,674 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 2,708 | $57.43 | $155,520.44 |
DisclosureSEC source: 0001099219-21-000075 · wf-form4_161429251319284.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,471 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 7,914 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000075 · wf-form4_161429251319284.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,179 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 5,224 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000075 · wf-form4_161429251319284.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,265 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 8,275 restricted stock units previously reported on Table II. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 14:00 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | GrantRestricted Stock Units · Derivative | 1,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003254 · doc4.xml · derivative · entry 1 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,283 Underlying: Common Stock · 1,283 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · derivative.exercise_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2022. F2 · derivative.expiration_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2022. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 14:01 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | GrantRestricted Stock Units · Derivative | 403 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-014233 · doc4.xml · derivative · entry 1 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403 Underlying: Common Stock · 403 shares Expires 2021-12-02 F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:22 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000121 · wf-form4_158335695283665.xml · derivative · entry 9 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,670 Underlying: Common Stock · 1,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F4 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. F4 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:22 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000121 · wf-form4_158335695283665.xml · derivative · entry 8 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,191 Underlying: Common Stock · 1,191 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F4 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. F4 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:22 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000121 · wf-form4_158335695283665.xml · derivative · entry 7 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · shares: Includes 126 restricted stock units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the restricted stock units in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the restricted stock units. F4 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. F4 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. F3 · derivative.underlying_shares: Includes 126 restricted stock units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the restricted stock units in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the restricted stock units. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:22 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 454 | $44.56 | $20,230.24 |
DisclosureSEC source: 0001099219-20-000121 · wf-form4_158335695283665.xml · nonDerivative · entry 6 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,766 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the restricted stock unit payout. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:22 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000121 · wf-form4_158335695283665.xml · nonDerivative · entry 5 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:22 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 405 | $44.56 | $18,046.80 |
DisclosureSEC source: 0001099219-20-000121 · wf-form4_158335695283665.xml · nonDerivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,886 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the restricted stock unit payout. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:22 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,191 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000121 · wf-form4_158335695283665.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:22 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 401 | $44.56 | $17,868.56 |
DisclosureSEC source: 0001099219-20-000121 · wf-form4_158335695283665.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,100 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the restricted stock unit payout. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:22 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,179 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000121 · wf-form4_158335695283665.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:42 UTC | METLIFE INC MET · Entity 488 | GrantRestricted Stock Units · Derivative | 4,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,414 Underlying: Common Stock · 4,414 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. F5 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:42 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 13,241 | $0.00 Strike: $47.58 | $0.00 |
DisclosureSEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · derivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,241 Underlying: Common Stock · 13,241 shares Expires 2030-02-24 F3 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:42 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 2,221 | $47.58 | $105,675.18 |
DisclosureSEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,322 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:42 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 6,458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,543 F1 · price: Shares acquired from the payout of 2017-2019 performance share award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.